MPM has a uniquely poor somatic mutational landscape, mainly driven by environmental
selective pressure. This feature has dramatically limited the development of effective …

Background ONCOS-102, an oncolytic adenovirus expressing granulocyte-macrophage
colony-stimulating factor, can alter the tumor microenvironment to an immunostimulatory …

Malignant peritoneal mesothelioma (MPeM) is a rare primary malignant tumor originating
from peritoneal mesothelial cells. Insufficient specificity of the symptoms and their frequent …

Objectives Malignant pleural mesothelioma (MPM) is an aggressive cancer which at large is
not amenable to curative surgery. Despite the recent approval of immune checkpoint …

BACKGROUND Malignant peritoneal mesothelioma (MPeM) is a rare cancer with a poor
prognosis at advanced stage, and the standard first-line treatment for inoperable patients is …

Paratesticular malignant mesothelioma (MM) is a rare tumor frequently associated with
asbestos exposure. Therefore, we present an even rarer case of a 78-year-old male patient …

Background Pleural mesothelioma, characterized by a dismal prognosis even with
multimodal therapy, has seen emerging interest in immune checkpoint inhibitors (ICIs) due …

Notre équipe étudie l'utilisation de virus oncolytiques dans le mésothéliome pleural malin
(MPM). En particulier, nous étudions les mécanismes de sensibilité et de résistance des …

Pleural mesothelioma (MPM) is a rare and aggressive cancer of the pleura, mainly induced
by asbestos exposure. The standard chemotherapy of MPM consists in a combination of …

Background: Malignant pleural mesothelioma (MPM) is a neoplasm with low incidence in
small animals, and the possible causes are poorly elucidated but may be related to contact …